The Crestor generics are coming. AstraZeneca failed its last-ditch attempt to protect the blockbuster brand Tuesday, when a federal judge denied its bid for a restraining order. AstraZeneca had argued ...
FDA approves Crestor’s generic rivals, much to Astrazeneca’s dismay The Food and Drug Administration on Wednesday approved several generic versions of the popular cholesterol-lowering drug Crestor, ...
A federal judge late Tuesday refused to issue an order that would have blocked several companies from selling generic versions of the Crestor cholesterol pill in the US. The decision is a blow to ...
AstraZeneca is trying to invoke the Orphan Drug Act to protect its blockbuster, on the grounds it is approved to treat a rare pediatric condition. Updates with report of FDA approval for generic ...
AstraZeneca has lost its bid to stop the US Food and Drug Administration from approving any new generic versions of its blockbuster statin, Crestor. On Tuesday in Washington, DC, US District Judge ...
AstraZeneca faces just one generic version of its blockbuster statin med Crestor. And the U.K. drug giant wants to keep it that way. The company has filed a citizen petition with the FDA contending ...
AstraZeneca has been issued a generic challenge to its blockbuster cholesterol drug Crestor (rosuvastatin calcium) by Canada’s Cobalt pharmaceuticals. Cobalt is seeking approval to sell a copycat ...
The Food and Drug Administration (FDA) has approved Watson's Rosuvastatin Calcium Tablets, the first generic version of AstraZeneca's Crestor. The Food and Drug Administration (FDA) has approved ...
A federal judge late Tuesday refused to issue an order that would have blocked several companies from selling generic versions of the Crestor cholesterol pill in the US. The decision is a blow to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback